No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Benzamides / administration & dosage
-
Benzamides / adverse effects*
-
Child, Preschool
-
Dasatinib
-
Daunorubicin / administration & dosage
-
Dexamethasone / administration & dosage
-
Drug Substitution
-
Female
-
Humans
-
Imatinib Mesylate
-
Parenteral Nutrition, Total
-
Piperazines / administration & dosage
-
Piperazines / adverse effects*
-
Pneumatosis Cystoides Intestinalis / chemically induced*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects*
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects*
-
Recurrence
-
Thiazoles / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Thiazoles
-
Vincristine
-
Dexamethasone
-
Imatinib Mesylate
-
Asparaginase
-
Dasatinib
-
Daunorubicin